Literature DB >> 16491123

Ganglioside GM3 promotes cell migration by regulating MAPK and c-Fos/AP-1.

A Hashiramoto1, H Mizukami, T Yamashita.   

Abstract

Gangliosides have been proposed as modulators of transmembrane signaling. Recently, GM3, a glycosphingolipid containing monosaialic acids, is thought to be one of the key molecules of signal transduction in mammalian cells. In this study, we used mouse embryonic fibroblast cell lines (MEFs) established from sialyltransferase-I knockout mice (GM3 synthase KO mice) to evaluate the regulation of mitogenic signals by gangliosides. Cell proliferation assay revealed a higher growth potential of GM3 KO MEFs. Immunoblots showed upregulation of Ras/Raf/MEK/ERK pathway in GM3 KO MEFs, and these signals resulted in enhanced translocation of ERK into the nuclei. Further, both exogenous and endogenous add-back of GM3 decreased the activities of MAPK in GM3 KO MEFs. In addition, GM3 KO MEFs formed foci in high-density culture condition, and analyses of cell cycle modulators revealed the resistance of GM3 KO MEFs for entering cell cycle arrest. Finally, sustained expressions of c-Fos in GM3 KO MEFs were shown to correlate with DNA-binding activity between c-Fos and AP-1. These results demonstrate that the deletion of sialyltransferase-I changes the character of MEFs to a highly activated state of the MAPK pathway, indicating the critical role of GM3 as a regulator of membrane-transmitted signals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16491123     DOI: 10.1038/sj.onc.1209416

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

1.  Membrane interaction of Pasteurella multocida toxin involves sphingomyelin.

Authors:  Michael C Brothers; Mengfei Ho; Ram Maharjan; Nathan C Clemons; Yuka Bannai; Mark A Waites; Melinda J Faulkner; Theresa B Kuhlenschmidt; Mark S Kuhlenschmidt; Steven R Blanke; Chad M Rienstra; Brenda A Wilson
Journal:  FEBS J       Date:  2011-10-20       Impact factor: 5.542

2.  A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation.

Authors:  Luigi Boccuto; Kazuhiro Aoki; Heather Flanagan-Steet; Chin-Fu Chen; Xiang Fan; Frank Bartel; Marharyta Petukh; Ayla Pittman; Robert Saul; Alka Chaubey; Emil Alexov; Michael Tiemeyer; Richard Steet; Charles E Schwartz
Journal:  Hum Mol Genet       Date:  2013-09-10       Impact factor: 6.150

Review 3.  Sialylation in protostomes: a perspective from Drosophila genetics and biochemistry.

Authors:  Kate Koles; Elena Repnikova; Galina Pavlova; Leonid I Korochkin; Vladislav M Panin
Journal:  Glycoconj J       Date:  2008-06-21       Impact factor: 2.916

4.  Reduced GM1 ganglioside in CFTR-deficient human airway cells results in decreased β1-integrin signaling and delayed wound repair.

Authors:  Yutaka Itokazu; Richard E Pagano; Andreas S Schroeder; Scott M O'Grady; Andrew H Limper; David L Marks
Journal:  Am J Physiol Cell Physiol       Date:  2014-02-05       Impact factor: 4.249

5.  Lipidomic Profiling Links the Fanconi Anemia Pathway to Glycosphingolipid Metabolism in Head and Neck Cancer Cells.

Authors:  Xueheng Zhao; Marion G Brusadelli; Sharon Sauter; Melinda Butsch Kovacic; Wujuan Zhang; Lindsey E Romick-Rosendale; Paul F Lambert; Kenneth D R Setchell; Susanne I Wells
Journal:  Clin Cancer Res       Date:  2018-03-12       Impact factor: 12.531

6.  Monosialotetrahexosy-1 ganglioside attenuates diabetes-enhanced brain damage after transient forebrain ischemia and suppresses phosphorylation of ERK1/2 in the rat brain.

Authors:  Jian-Zhong Zhang; Li Jing; Yi Ma; Feng-Ying Guo; Yue Chang; P Andy Li
Journal:  Brain Res       Date:  2010-06-08       Impact factor: 3.252

7.  Molecular dynamics study of the conformations of glycosidic linkages in sialic acid modified ganglioside GM3 analogues.

Authors:  G Jaishree; D Jeya Sundara Sharmila
Journal:  Glycoconj J       Date:  2014-06-10       Impact factor: 2.916

8.  Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease.

Authors:  Adel Ersek; Ke Xu; Aristotelis Antonopoulos; Terry D Butters; Ana Espirito Santo; Youridies Vattakuzhi; Lynn M Williams; Katerina Goudevenou; Lynett Danks; Andrew Freidin; Emmanouil Spanoudakis; Simon Parry; Maria Papaioannou; Evdoxia Hatjiharissi; Aristeidis Chaidos; Dominic S Alonzi; Gabriele Twigg; Ming Hu; Raymond A Dwek; Stuart M Haslam; Irene Roberts; Anne Dell; Amin Rahemtulla; Nicole J Horwood; Anastasios Karadimitris
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808

9.  Multiple phenotypic changes in mice after knockout of the B3gnt5 gene, encoding Lc3 synthase--a key enzyme in lacto-neolacto ganglioside synthesis.

Authors:  Chien-Tsun Kuan; Jinli Chang; Jan-Eric Mansson; Jianjun Li; Charles Pegram; Pam Fredman; Roger E McLendon; Darell D Bigner
Journal:  BMC Dev Biol       Date:  2010-11-18       Impact factor: 1.978

10.  Ganglioside GM3 has an essential role in the pathogenesis and progression of rheumatoid arthritis.

Authors:  Yukinori Tsukuda; Norimasa Iwasaki; Naoki Seito; Masashi Kanayama; Naoki Fujitani; Yasuro Shinohara; Yasuhiko Kasahara; Tomohiro Onodera; Koji Suzuki; Tsuyoshi Asano; Akio Minami; Tadashi Yamashita
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.